adagrasib
mirati
['adagrasib', 'lung', 'krystal-1']
 discusses the adagrasib in patients with non small cell lung cancer in the phase 2 krystal-1 trial with at #asco2022 
The US Oncology Network is one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America.